Dr. Vimal Krishnan, MD
Pathology (Cytopathology Physician)
- Medicare participating
At a glance
- Years since graduation
- 11
- In the NPI registry since
- 2020
- Medicare patients seen, 2024
- 363
Licensed in California since 2020, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2020Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cytopathology Physician primary
CA license A167729 (first issued 2020; current) -
Anatomic Pathology Physician
CA license A167729 (first issued 2020; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UCSF Medical Center San Francisco, CA
- UCSF Health St. Mary's Hospital San Francisco, CA
Medical groups
- University of California San Francisco (1,839 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 363
- Services billed
- 1,276
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 161 | 103 |
| Special stained specimen slides to examine tissue, each additional procedure | 154 | 45 |
| Cell examination of specimen, selective cellular enhancement technique | 111 | 106 |
| Evaluation of fine needle aspirate with interpretation and report | 110 | 92 |
| Evaluation of fine needle aspirate | 101 | 86 |
| Special stained specimen slides to examine tissue, initial procedure | 54 | 51 |
| Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | 34 | 13 |
| Pathology examination of tissue using a microscope, moderately high complexity | 28 | 16 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 28 | 28 |
| New patient office or other outpatient visit, 30-44 minutes | 26 | 26 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.